Filing Details
- Accession Number:
- 0001209191-12-020640
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-30 18:44:05
- Reporting Period:
- 2012-03-29
- Filing Date:
- 2012-03-30
- Accepted Time:
- 2012-03-30 17:44:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138400 | Biomimetic Therapeutics Inc. | BMTI | Surgical & Medical Instruments & Apparatus (3841) | 621786244 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1362148 | Eugene Samuel Lynch | Biomimetic Therapeutics, Inc. 389 Nichol Mill Lane Franklin TN 37067 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-03-29 | 30,638 | $2.38 | 1,200,029 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-03-30 | 19,362 | $2.46 | 1,219,391 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-03-30 | 20,000 | $2.40 | 1,239,391 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,550 | Indirect | By Wife |
Footnotes
- This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.33 and $2.40. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $2.42 and $2.49. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.
- Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.